Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled trial of V260 rotavirus vaccine in infants
2016-005159-25Phase 3
- Sponsor
- Merck & Co.
- Start
- Dec 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of rotavirus vaccine, live, oral, pentavalent in rotaviral diarrhea, sponsored by Merck & Co..
02
Drugs
rotavirus vaccine, live, oral, pentavalent
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on 2016-005159-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-005159-25.